Report
EUR 12.94 For Business Accounts Only

Increased risk weighs on MAYORA INDAH, penalising its rating down to Neutral

The independent financial analyst theScreener just lowered the general evaluation of MAYORA INDAH (ID), active in the Food Products industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as moderately risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Neutral. As of the analysis date December 10, 2021, the closing price was IDR 2,140.00 and its target price was estimated at IDR 1,952.92.
Underlying
Mayora Indah

Co. is engaged in the manufacture of biscuits, candy, wafers, chocolate candy and jelly. Co. produces Roma Cookies, Butter Cookies Danisa, Kopiko candies, chocolate Wafer Roma, Beng-beng, Astor, Choki-choki, Pee Wee, and Long Jelly. Through its subsidiaries, Co. is also engaged in the processing of coffee powder, instant coffee, and cocoa beans.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch